Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-Human DST/Dystonin Polyclonal Antibody

Catalog #:   PHF97201 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: Q03001-3
Overview

Catalog No.

PHF97201

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Human DST/Dystonin (Lys1870-Ser2649).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000

Target

Isoform 3 of Dystonin, 230 kDa bullous pemphigoid antigen, 230/240 kDa bullous pemphigoid antigen, Bullous pemphigoid antigen 1, BPA, Bullous pemphigoid antigen, Dystonia musculorum protein, Hemidesmosomal plaque protein, DST, BP230, BP240, BPAG1, DMH, DT, KIAA0728

Concentration

2.21 mg/ml

Purification

Purified by antigen affinity column.

Accession

Q03001-3

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • Western Blot
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with DST/Dystonin antibody (PHF97201) at 1 μg/ml.

    Lane 1: Recombinant protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 91 kDa
    Observed MW: 91 kDa
References

Comparative performance and age dependence of tuberculin and defined antigen bovine tuberculosis skin tests assessed with Bayesian latent class analysis., PMID:40473835

Matrix metalloproteinase-9 (MMP-9): A macromolecular mediator in CNS infections: A review., PMID:40328391

SNAP-Tag-Based Recombinant Photoimmunotherapeutic Agents for the Selective Detection and Killing of Light-Accessible Melanotransferrin-Expressing Melanoma and Triple-Negative Breast Cancer., PMID:40326388

Cross-variant immune shield: computational multiepitope vaccine design against B.617.2 to Omicron sub-lineages in SARS-CoV-2., PMID:40202023

In vitro and in vivo neutralization of Dengue virus by a single domain antibody., PMID:40180606

Impact in the humoral and cellular immune response to SARS-CoV-2 variants after primary vaccination with AZD1222/COVISHIELD protocol in healthy adults., PMID:39938313

Correlation of BP180, BP230, and type VII collagen antibody titers in serum, blister fluid, erosion, and saliva in pemphigoid diseases., PMID:39916594

Clinical characteristics of bullous pemphigoid patients of different ages and the possible mechanism., PMID:39821084

Bullous pemphigoid and mucous membrane pemphigoid humoral responses differ in reactivity towards BP180 midportion and BP230., PMID:39676877

Characterization of differentially regulated carboxypeptidase (metallopeptidase M32) protein in Miltefosine resistant Leishmania donovani parasites., PMID:39674486

Antimalarial Drug Artemotil Promotes Induction of Type 1 Regulatory T Cells., PMID:39607628

Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial., PMID:39532861

Ecological and Reproductive Cycles Drive Henipavirus Seroprevalence in the African Straw-Coloured Fruit Bat (Eidolon helvum)., PMID:39530036

Detection of anti-leptospiral antibodies using recombinant ErpY-like lipoprotein based latex agglutination test for serodiagnosis of animal leptospirosis., PMID:39439206

Unveiling the impact of Leptospira TolC efflux protein on host tissue adherence, complement evasion, and diagnostic potential., PMID:39392312

Co-regulation of innate and adaptive immune responses induced by ID93+GLA-SE vaccination in humans., PMID:39381003

Bullous Pemphigoid Severity and Levels of Antibodies to BP180 and BP230: A Systematic Review and Meta-Analysis., PMID:39356527

7D, a small molecule inhibits dengue infection by increasing interferons and neutralizing-antibodies via CXCL4:CXCR3:p38:IRF3 and Sirt1:STAT3 axes respectively., PMID:39284947

Diabetic Peripheral Neuropathy: Emerging Treatments of Neuropathic Pain and Novel Diagnostic Methods., PMID:39282925

Head-to-head comparison of composite and individual biomarkers to predict clinical benefit to PD-1 blockade in non-small cell lung cancer., PMID:39083541

Predicting immune response targets in orthoflaviviruses through sequence homology and computational analysis., PMID:39083139

Hump-Nosed Pit Viper (Hypnale hypnale) Venom-Induced Irreversible Red Blood Cell Aggregation, Inhibition by Monovalent Anti-Venom and N-Acetylcysteine., PMID:38920625

Cross-reactivity of hantavirus antibodies after immunization with PUUV antigens., PMID:38779849

Anti-BP230 IgE autoantibodies in bullous pemphigoid intraindividually correlate with disease activity., PMID:38582700

Status of B-Lymphocyte Subsets and Their Homing Markers in Patients With Post-Kala-Azar Dermal Leishmaniasis., PMID:38527908

Ex Vivo Efficacy of SAR442257 Anti-CD38 Trispecific T-cell Engager in Multiple Myeloma Relapsed After Daratumumab and BCMA-targeted Therapies., PMID:38421887

Safety and Efficacy of Switching SAR341402 Insulin Aspart and Originator Insulin Aspart vs Continuous Use of Originator Insulin Aspart in Adults With Type 1 Diabetes: The GEMELLI X Trial., PMID:38420944

Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies., PMID:38383515

Apolipoprotein L1 (APOL1) renal risk variant-mediated podocyte cytotoxicity depends on African haplotype and surface expression., PMID:38355600

Therapeutic potential of tocotrienols as chemosensitizers in cancer therapy., PMID:38353331

Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma., PMID:38309721

Temporal dynamics of the early immune response following Mycobacterium bovis infection of cattle., PMID:38297023

Epigenetic reprogramming of T cells: unlocking new avenues for cancer immunotherapy., PMID:38233727

A Correlation Study to Comprehend the SAR-CoV-2 Viral Load, Antiviral Antibody Titer, and Severity of COVID-19 Symptoms Post-infection Amongst the Vaccinated Population in Kamrup District of As sam, Northeast India., PMID:38231052

Subclinical circulation of Chicken infectious anaemia virus- A Sero-molecular study., PMID:38155335

Functionalized Graphene Quantum Dots (GQDs) based Label-Free Optical Fluorescence Sensor for CD59 Antigen Detection and Cellular Bioimaging., PMID:37976023

Mutations in S2 subunit of SARS-CoV-2 Omicron spike strongly influence its conformation, fusogenicity, and neutralization sensitivity., PMID:37861334

TGF-β in correlation with tumor progression, immunosuppression and targeted therapy in colorectal cancer., PMID:37855975

Characterization of differential distribution patterns between mitofusin isoforms and their interaction in developing skeletal muscles of rat., PMID:37814838

Conditionally Active, pH-Sensitive Immunoregulatory Antibodies Targeting VISTA and CTLA-4 Lead an Emerging Class of Cancer Therapeutics., PMID:37753969

Computer-aided Affinity Enhancement of a Cross-reactive Antibody against Dengue Virus Envelope Domain III., PMID:37735329

Multicolor Photoluminescent Carbon Dots à La Carte for Biomedical Applications., PMID:37715711

Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4., PMID:37673858

Prognostic significance of circulating microparticles in IgA nephropathy., PMID:37615844

Neutralizing Antibodies in COVID-19 Serum from Tatarstan, Russia., PMID:37373331

Surfactants reduce aggregation of monoclonal antibodies in cell culture medium with improvement in performance of mammalian cell culture., PMID:37348004

Protein Engineering, a Robust Tool to Engineer Novel Functions in Protein., PMID:37211849

Inhibiting membrane rupture with NINJ1 antibodies limits tissue injury., PMID:37196676

Three year post heart transplant outcomes of desensitized durable mechanical circulatory support patients., PMID:37150473

Seed Transmission of Begomoviruses: A Potential Threat for Bitter Gourd Cultivation., PMID:36987084

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human DST/Dystonin Polyclonal Antibody [PHF97201]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only